In these cells, PSD‐95 levels are reduced in tandem with a reduction in surface expression of GluA1‐containing AMPARs,38 supporting the role of synaptic dysfunction in the early progression of AD. The gene discussed is GRIA1; the disease is Alzheimer disease.